Literature DB >> 28651908

Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naïve patients with schizophrenia presenting with first episode psychosis.

Jing Dai1, Xiangdong Du2, Guangzhong Yin2, Yingyang Zhang2, Haishen Xia3, Xiaosi Li3, Rylan Cassidy4, Qingchun Tong4, Dachun Chen5, Antonio Lucio Teixeira6, Yingjun Zheng7, Yuping Ning7, Jair C Soares6, Man-Xi He8, Xiang Yang Zhang9.   

Abstract

Depressive symptoms are common in first episode schizophrenia. However, the prevalence and its associations of comorbid depressive symptoms with clinical variables are less well characterized in Chinese Han patients with schizophrenia. In this cross-sectional study, we recruited 240 first-episode and drug naïve (FEDN) inpatients with schizophrenia. All patients were rated on the 17-item Hamilton Depression Rating Scale (HAMD-17) to measure depressive symptoms, and also on the Positive and Negative Syndrome Scale (PANSS) for psychopathology. Our results showed that 131 patients had a total score of 8 or more points on HAMD-17, making the prevalence of comorbid depressive symptoms 54.6%. Fewer women (48.1%, 62 of 129) than men (62.2%, 69 of 111) had comorbid depressive symptoms. Compared to those patients without depressive symptoms, those with depressive symptoms showed higher PANSS total, general psychopathology, cognitive factor and negative symptom scores (all p<0.05). Further stepwise multiple logistic regression analysis indicated that the PANSS general psychopathology, the PANSS total score and gender (all p<0.05) remained significantly associated with depressive symptoms. In addition, correlation analysis showed significant correlations between HAMD total score and the following parameters: the PANSS general psychopathology, total score, and cognitive factor (Bonferroni corrected p's<0.05). Our results suggest that depressive symptoms occur with high prevalence in FEND schizophrenia in a Chinese Han population, and show association with general psychopathology, as well as with cognitive impairment.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Association; Depression; Prevalence; Psychopathology; Schizophrenia

Mesh:

Year:  2017        PMID: 28651908     DOI: 10.1016/j.schres.2017.06.029

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  Major depressive disorder and attenuated negative symptoms in a child and adolescent sample with psychosis risk syndrome: the CAPRIS study.

Authors:  Marta Rodríguez-Pascual; Xavier Álvarez-Subiela; Jordina Tor; Marta Pardo; Elena de la Serna; Gisela Sugranyes; Olga Puig; Inmaculada Baeza; Montserrat Dolz
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-04-24       Impact factor: 5.349

2.  Misdiagnosis, detection rate, and associated factors of severe psychiatric disorders in specialized psychiatry centers in Ethiopia.

Authors:  Getinet Ayano; Sileshi Demelash; Zegeye Yohannes; Kibrom Haile; Mikiyas Tulu; Dawit Assefa; Abel Tesfaye; Kelemua Haile; Melat Solomon; Asrat Chaka; Light Tsegay
Journal:  Ann Gen Psychiatry       Date:  2021-02-02       Impact factor: 3.455

3.  Structural abnormalities of cingulate cortex in patients with first-episode drug-naïve schizophrenia comorbid with depressive symptoms.

Authors:  Gao-Xia Wei; Likun Ge; Li-Zhen Chen; Bo Cao; Xiangyang Zhang
Journal:  Hum Brain Mapp       Date:  2020-12-09       Impact factor: 5.038

4.  Gender Differences of Schizophrenia Patients With and Without Depressive Symptoms in Clinical Characteristics.

Authors:  Ruimei Liu; Xinyu Fang; Lingfang Yu; Dandan Wang; Zenan Wu; Chaoyue Guo; Xinyue Teng; Juanjuan Ren; Chen Zhang
Journal:  Front Psychiatry       Date:  2022-01-13       Impact factor: 4.157

5.  Association Between Depressive Symptoms and Serum Brain-Derived Neurotrophic Factor Levels in Patients With First-Episode and Drug-Naïve Schizophrenia.

Authors:  Yuxuan Wu; Xiangdong Du; Ruchang Yang; Yan Yue; Ruijie Peng; Siqi Wu; Haitao Wang; Yue Zhou; Xiaojia Fang; Nian Yuan; Ronghua Li; Jun Zhang; Siyun Zou; Xueli Zhao; Xiaoli Lyu; Zhe Li; Xiaobin Zhang; Xiangyang Zhang
Journal:  Front Psychiatry       Date:  2022-06-09       Impact factor: 5.435

6.  Impaired Binocular Depth Perception in First-Episode Drug-Naive Patients With Schizophrenia.

Authors:  Zhengchun Wang; Zhipeng Yu; Zhichao Pan; Keyu Zhao; Qiqi Zhao; Dongsheng Zhou; Hao-Wei Shen; Xiangping Wu
Journal:  Front Psychol       Date:  2018-05-31

7.  The prevalence and associated factors of depression among patients with schizophrenia in Addis Ababa, Ethiopia, cross-sectional study.

Authors:  Tolesa Fanta; Desalegn Bekele; Getinet Ayano
Journal:  BMC Psychiatry       Date:  2020-01-02       Impact factor: 3.630

8.  Risk Factors of Metabolic Syndrome in Community-Dwelling People with Schizophrenia.

Authors:  Min Jung Sun; Mi Heui Jang
Journal:  Int J Environ Res Public Health       Date:  2020-09-14       Impact factor: 3.390

9.  Depression among Patients with Schizophrenia in Ethiopian Mental Health Hospital: Association with Sociodemographic and Clinical Variables: A Cross-Sectional Study.

Authors:  Mandaras Tariku; Tilahun Ali; Tadesse Misgana; Mohammedamin Hajure; Henock Asfaw
Journal:  Depress Res Treat       Date:  2021-02-09

10.  Outcomes reported in randomised controlled trials of major depressive disorder in older adults: protocol for a methodological review.

Authors:  Myanca Rodrigues; Nitika Sanger; Alexander Dufort; Stephanie Sanger; Balpreet Panesar; Alessia D'Elia; Sameer Parpia; Zainab Samaan; Lehana Thabane
Journal:  BMJ Open       Date:  2021-11-01       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.